Free Trial

IceCure Medical (ICCM) Competitors

IceCure Medical logo
$0.73 +0.03 (+4.21%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$0.73 0.00 (0.00%)
As of 11/13/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICCM vs. GUTS, ICU, TMDIF, INBS, and NDRA

Should you buy IceCure Medical stock or one of its competitors? IceCure Medical's main competitors and comparable companies include Fractyl Health (GUTS), SeaStar Medical (ICU), Titan Medical (TMDIF), Intelligent Bio Solutions (INBS), and ENDRA Life Sciences (NDRA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does IceCure Medical compare to Fractyl Health?

IceCure Medical (NASDAQ:ICCM) and Fractyl Health (NASDAQ:GUTS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

In the previous week, Fractyl Health had 4 more articles in the media than IceCure Medical. MarketBeat recorded 8 mentions for Fractyl Health and 4 mentions for IceCure Medical. IceCure Medical's average media sentiment score of 0.61 beat Fractyl Health's score of 0.52 indicating that IceCure Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fractyl Health
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fractyl Health has a net margin of 0.00% compared to IceCure Medical's net margin of -427.67%. IceCure Medical's return on equity of -174.26% beat Fractyl Health's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-427.67% -174.26% -112.58%
Fractyl Health N/A -867.40%-83.57%

IceCure Medical has higher revenue and earnings than Fractyl Health. IceCure Medical is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M0.74-$15.06M-$8.52N/A
Fractyl Health$90K133.13-$140.95M-$10.56N/A

IceCure Medical has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.9, meaning that its stock price is 190% more volatile than the broader market.

IceCure Medical presently has a consensus target price of $30.00, suggesting a potential upside of 4,009.59%. Fractyl Health has a consensus target price of $50.25, suggesting a potential upside of 5,461.09%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts clearly believe Fractyl Health is more favorable than IceCure Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Fractyl Health
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

0.6% of IceCure Medical shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 8.4% of Fractyl Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Fractyl Health beats IceCure Medical on 9 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

SeaStar Medical presently has a consensus price target of $8.00, indicating a potential upside of 854.20%. IceCure Medical has a consensus price target of $30.00, indicating a potential upside of 4,009.59%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

SeaStar Medical has a beta of -1.07, suggesting that its stock price is 207% less volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market.

SeaStar Medical has higher earnings, but lower revenue than IceCure Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M3.63-$12.15M-$3.91N/A
IceCure Medical$3.38M0.74-$15.06M-$8.52N/A

In the previous week, SeaStar Medical had 5 more articles in the media than IceCure Medical. MarketBeat recorded 9 mentions for SeaStar Medical and 4 mentions for IceCure Medical. IceCure Medical's average media sentiment score of 0.61 beat SeaStar Medical's score of 0.04 indicating that IceCure Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
IceCure Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

IceCure Medical has a net margin of -427.67% compared to SeaStar Medical's net margin of -678.24%. IceCure Medical's return on equity of -174.26% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-678.24% -199.99% -129.30%
IceCure Medical -427.67%-174.26%-112.58%

Summary

IceCure Medical beats SeaStar Medical on 11 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Titan Medical?

IceCure Medical (NASDAQ:ICCM) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

In the previous week, IceCure Medical had 4 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for IceCure Medical and 0 mentions for Titan Medical. IceCure Medical's average media sentiment score of 0.61 beat Titan Medical's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company Overall Sentiment
IceCure Medical Positive
Titan Medical Neutral

Titan Medical has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M0.74-$15.06M-$8.52N/A
Titan Medical$17.63M0.52$6.95M$0.051.60

Titan Medical has a net margin of 0.00% compared to IceCure Medical's net margin of -427.67%. Titan Medical's return on equity of -82.31% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-427.67% -174.26% -112.58%
Titan Medical N/A -82.31%-51.47%

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

IceCure Medical has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

IceCure Medical presently has a consensus target price of $30.00, indicating a potential upside of 4,009.59%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe IceCure Medical is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

IceCure Medical and Titan Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Intelligent Bio Solutions?

IceCure Medical (NASDAQ:ICCM) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

Intelligent Bio Solutions has a net margin of -269.28% compared to IceCure Medical's net margin of -427.67%. Intelligent Bio Solutions' return on equity of -150.00% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-427.67% -174.26% -112.58%
Intelligent Bio Solutions -269.28%-150.00%-83.38%

IceCure Medical has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.48, meaning that its share price is 348% more volatile than the broader market.

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 2.8% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

IceCure Medical presently has a consensus price target of $30.00, indicating a potential upside of 4,009.59%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts plainly believe IceCure Medical is more favorable than Intelligent Bio Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Intelligent Bio Solutions
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Intelligent Bio Solutions has higher revenue and earnings than IceCure Medical. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M0.74-$15.06M-$8.52N/A
Intelligent Bio Solutions$4.22M1.38-$12.43M-$6.38N/A

In the previous week, Intelligent Bio Solutions had 1 more articles in the media than IceCure Medical. MarketBeat recorded 5 mentions for Intelligent Bio Solutions and 4 mentions for IceCure Medical. Intelligent Bio Solutions' average media sentiment score of 1.15 beat IceCure Medical's score of 0.61 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Intelligent Bio Solutions
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Intelligent Bio Solutions beats IceCure Medical on 12 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to ENDRA Life Sciences?

ENDRA Life Sciences (NASDAQ:NDRA) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

ENDRA Life Sciences has a net margin of 0.00% compared to IceCure Medical's net margin of -427.67%. IceCure Medical's return on equity of -174.26% beat ENDRA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ENDRA Life SciencesN/A -246.34% -150.81%
IceCure Medical -427.67%-174.26%-112.58%

ENDRA Life Sciences has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 10.0% of ENDRA Life Sciences shares are owned by company insiders. Comparatively, 2.4% of IceCure Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

ENDRA Life Sciences currently has a consensus target price of $25.00, suggesting a potential upside of 466.89%. IceCure Medical has a consensus target price of $30.00, suggesting a potential upside of 4,009.59%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than ENDRA Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ENDRA Life Sciences
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

ENDRA Life Sciences has higher earnings, but lower revenue than IceCure Medical. ENDRA Life Sciences is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ENDRA Life SciencesN/AN/A-$7.03M-$6.38N/A
IceCure Medical$3.38M0.74-$15.06M-$8.52N/A

In the previous week, IceCure Medical had 3 more articles in the media than ENDRA Life Sciences. MarketBeat recorded 4 mentions for IceCure Medical and 1 mentions for ENDRA Life Sciences. ENDRA Life Sciences' average media sentiment score of 1.27 beat IceCure Medical's score of 0.61 indicating that ENDRA Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
ENDRA Life Sciences Positive
IceCure Medical Positive

Summary

IceCure Medical beats ENDRA Life Sciences on 9 of the 15 factors compared between the two stocks.

Get IceCure Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICCM vs. The Competition

MetricIceCure MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.50M$6.01B$7.89B$12.09B
Dividend YieldN/A1.68%2.47%4.54%
P/E RatioN/A36.0932.5827.39
Price / Sales0.745.628.825.89
Price / CashN/A24.1821.0222.32
Price / Book0.205.054.803.95
Net Income-$15.06M$143.92M$3.52B$391.78M
7 Day Performance7.24%-1.14%-1.52%-0.34%
1 Month Performance-29.81%-2.38%-3.54%-5.79%
1 Year Performance-96.59%1.91%1.45%-5.71%

IceCure Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICCM
IceCure Medical
2.8901 of 5 stars
$0.73
+4.2%
$30.00
+4,009.6%
N/A$2.50M$3.38MN/A68
GUTS
Fractyl Health
2.8165 of 5 stars
$0.81
-9.6%
$50.25
+6,098.3%
N/A$10.75MN/AN/A73
ICU
SeaStar Medical
3.738 of 5 stars
$1.90
-3.1%
$8.00
+321.1%
N/A$10.11M$1.23MN/A17
TMDIF
Titan Medical
N/A$0.09
+10.2%
N/AN/A$9.70M$17.63MN/A50
INBS
Intelligent Bio Solutions
1.5725 of 5 stars
$2.25
-1.7%
N/AN/A$7.47M$4.22MN/A60

Related Companies and Tools


This page (NASDAQ:ICCM) was last updated on 11/15/2026 by MarketBeat.com Staff.
From Our Partners